双层片技术:一种即时和受控给药的概念

Q3 Pharmacology, Toxicology and Pharmaceutics Journal of Pharmaceutical Negative Results Pub Date : 2023-01-14 DOI:10.47750/pnr.2023.14.s01.59
Deepika Gupta, Manju Pandey, Anup Maiti, Neelkanth M. Pujari, - Manju Pandey Director
{"title":"双层片技术:一种即时和受控给药的概念","authors":"Deepika Gupta, Manju Pandey, Anup Maiti, Neelkanth M. Pujari, - Manju Pandey Director","doi":"10.47750/pnr.2023.14.s01.59","DOIUrl":null,"url":null,"abstract":"Combination therapy has more popularity and various merits over monotherapy (conventional dosage forms). Bilayer tablet technology is the best and most recent used example of combination dosage formulation. In the last decade, the single-dose formulation has the combination of two or three active pharmaceutical ingredients (API) increased in pharmaceutical industry. It is known for promoting patient convenience and compliance by reducing the number of dosages and enhancing the bioavailability of dosage forms. Bilayer or multilayer tablets are innovative forms of conventional oral drug delivery systems. Bilayer layer can be the only technology that has been used in different APIs for synergistic effect, to enhance the bioavailability or to avoid the interaction between the incompatible substance by separating them physically, and to enable the development of different drug release profiles (sustained release or controlled release, etc). The goal of this review is to give a general overview of the development and production of bilayer tablet technology and to highlight the issues encountered during the production of bilayer tablets as well as the expected solutions to these problems.","PeriodicalId":16728,"journal":{"name":"Journal of Pharmaceutical Negative Results","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Bilayer Tablet Technology: A Concept Of Immediate And Controlled Drug Delivery\",\"authors\":\"Deepika Gupta, Manju Pandey, Anup Maiti, Neelkanth M. Pujari, - Manju Pandey Director\",\"doi\":\"10.47750/pnr.2023.14.s01.59\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Combination therapy has more popularity and various merits over monotherapy (conventional dosage forms). Bilayer tablet technology is the best and most recent used example of combination dosage formulation. In the last decade, the single-dose formulation has the combination of two or three active pharmaceutical ingredients (API) increased in pharmaceutical industry. It is known for promoting patient convenience and compliance by reducing the number of dosages and enhancing the bioavailability of dosage forms. Bilayer or multilayer tablets are innovative forms of conventional oral drug delivery systems. Bilayer layer can be the only technology that has been used in different APIs for synergistic effect, to enhance the bioavailability or to avoid the interaction between the incompatible substance by separating them physically, and to enable the development of different drug release profiles (sustained release or controlled release, etc). The goal of this review is to give a general overview of the development and production of bilayer tablet technology and to highlight the issues encountered during the production of bilayer tablets as well as the expected solutions to these problems.\",\"PeriodicalId\":16728,\"journal\":{\"name\":\"Journal of Pharmaceutical Negative Results\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pharmaceutical Negative Results\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.47750/pnr.2023.14.s01.59\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Negative Results","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47750/pnr.2023.14.s01.59","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

摘要

联合疗法比单一疗法(传统剂型)更受欢迎,有各种优点。双层片剂技术是最佳和最新使用的组合剂量配方的例子。在过去的十年中,单剂量制剂中两种或三种活性药物成分(API)的组合在制药行业中有所增加。众所周知,它通过减少剂量数量和提高剂型的生物利用度来促进患者的便利性和依从性。双层或多层片剂是传统口服药物递送系统的创新形式。双层可能是唯一一种在不同原料药中用于协同作用的技术,通过物理分离来提高生物利用度或避免不相容物质之间的相互作用,并能够开发不同的药物释放谱(持续释放或控制释放等)。本综述的目的是对双层片剂技术的开发和生产进行概述,并强调双层片剂生产过程中遇到的问题以及这些问题的预期解决方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Bilayer Tablet Technology: A Concept Of Immediate And Controlled Drug Delivery
Combination therapy has more popularity and various merits over monotherapy (conventional dosage forms). Bilayer tablet technology is the best and most recent used example of combination dosage formulation. In the last decade, the single-dose formulation has the combination of two or three active pharmaceutical ingredients (API) increased in pharmaceutical industry. It is known for promoting patient convenience and compliance by reducing the number of dosages and enhancing the bioavailability of dosage forms. Bilayer or multilayer tablets are innovative forms of conventional oral drug delivery systems. Bilayer layer can be the only technology that has been used in different APIs for synergistic effect, to enhance the bioavailability or to avoid the interaction between the incompatible substance by separating them physically, and to enable the development of different drug release profiles (sustained release or controlled release, etc). The goal of this review is to give a general overview of the development and production of bilayer tablet technology and to highlight the issues encountered during the production of bilayer tablets as well as the expected solutions to these problems.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Chinese Spinach (Amaranthus viridis Linn.) as Natural Molluscicide Against the Hatchability of Golden Apple Snail (Pomacea canaliculata Lamarck) Eggs Molluscicidal Activity Of Cashew (Anarcadium Occidentale Linn.) Apple Against Golden Apple Snail (Pomacea Canaliculata Lamarck) Effectiveness Of Simulation- Based Learning In Term Of Competency Regarding Pre-Term Newborn Care Among Nursing Students: An Quasi Experimental Study Synthesis, Characterization, Antibacterial Activity And Molecular Docking Studies Of Novel Nitrogen Based Indole-2-One Schiff’s Bases Emergency Obstetric Complications During Labour And Delivery Among Mothers Attending Maternity Teaching Hospital /Erbil City/ Iraq. A Cross-Sectional Study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1